Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
2.400
+0.160 (7.14%)
Dec 3, 2024, 10:19 AM EST - Market open
Lexaria Bioscience Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Lexaria Bioscience stock have an average target of 11, with a low estimate of 10 and a high estimate of 12. The average target predicts an increase of 358.35% from the current stock price of 2.40.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LEXX stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +316.68% | Dec 2, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +316.68% | Nov 25, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +316.68% | Jul 18, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +316.68% | Jul 10, 2024 |
Maxim Group | Maxim Group | Strong Buy Maintains $3 → $12 | Strong Buy | Maintains | $3 → $12 | +400.02% | Mar 5, 2024 |
Financial Forecast
Revenue This Year
411.74K
from 226.21K
Increased by 82.02%
Revenue Next Year
803.25K
from 411.74K
Increased by 95.09%
EPS This Year
-0.64
from -1.01
EPS Next Year
-0.40
from -0.64
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 556,500 | 1.0M | 1.2M | |||
Avg | 411,743 | 803,250 | 1.2M | |||
Low | 147,980 | 588,000 | 1.1M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 146.0% | 148.7% | 52.8% | |||
Avg | 82.0% | 95.1% | 48.4% | |||
Low | -34.6% | 42.8% | 42.7% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -0.42 | -0.35 | -0.36 |
Avg | -0.64 | -0.40 | -0.48 |
Low | -0.99 | -0.47 | -0.59 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.